189 related articles for article (PubMed ID: 17103306)
41. [Barrett's esophagus].
Kawano T; Iwai T
Nihon Rinsho; 2000 Sep; 58(9):1903-7. PubMed ID: 11004824
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
43. Dissociation and dispersion of claudin-3 from the tight junction could be one of the most sensitive indicators of reflux esophagitis in a rat model of the disease.
Oguro M; Koike M; Ueno T; Asaoka D; Mori H; Nagahara A; Uchiyama Y; Watanabe S
J Gastroenterol; 2011 May; 46(5):629-38. PubMed ID: 21373849
[TBL] [Abstract][Full Text] [Related]
44. Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus.
Souza RF; Shewmake KL; Shen Y; Ramirez RD; Bullock JS; Hladik CL; Lee EL; Terada LS; Spechler SJ
Am J Gastroenterol; 2005 Mar; 100(3):551-9. PubMed ID: 15743351
[TBL] [Abstract][Full Text] [Related]
45. Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus.
Verbeek RE; Siersema PD; Vleggaar FP; Ten Kate FJ; Posthuma G; Souza RF; de Haan J; van Baal JW
J Gastrointestin Liver Dis; 2016 Sep; 25(3):273-82. PubMed ID: 27689189
[TBL] [Abstract][Full Text] [Related]
46. Barrett's metaplasia develops from cellular reprograming of esophageal squamous epithelium due to gastroesophageal reflux.
Minacapelli CD; Bajpai M; Geng X; Cheng CL; Chouthai AA; Souza R; Spechler SJ; Das KM
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G615-G622. PubMed ID: 28336546
[TBL] [Abstract][Full Text] [Related]
47. Origins of Metaplasia in Barrett's Esophagus: Is this an Esophageal Stem or Progenitor Cell Disease?
Zhang W; Wang DH
Dig Dis Sci; 2018 Aug; 63(8):2005-2012. PubMed ID: 29675663
[TBL] [Abstract][Full Text] [Related]
48. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?
Coenraad M; Masclee AA; Straathof JW; Ganesh S; Griffioen G; Lamers CB
Am J Gastroenterol; 1998 Jul; 93(7):1068-72. PubMed ID: 9672332
[TBL] [Abstract][Full Text] [Related]
49. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.
Winters C; Spurling TJ; Chobanian SJ; Curtis DJ; Esposito RL; Hacker JF; Johnson DA; Cruess DF; Cotelingam JD; Gurney MS
Gastroenterology; 1987 Jan; 92(1):118-24. PubMed ID: 3781178
[TBL] [Abstract][Full Text] [Related]
50. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
51. [Histochemical diagnosis of short segment Barrett's esophagus].
Fujiyama Y; Ishizuka I; Koyama S
Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233
[TBL] [Abstract][Full Text] [Related]
52. Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features.
Pascarenco OD; Boeriu A; Mocan S; Pascarenco G; Drasoveanu S; Galeanu M; Dobru D
J Gastrointestin Liver Dis; 2014 Mar; 23(1):19-25. PubMed ID: 24689092
[TBL] [Abstract][Full Text] [Related]
53. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
Schilling D; Spiethoff A; Rosenbaum A; Hartmann D; Eickhoff A; Jakobs R; Weickert U; Rebe M; Bohrer MH; Riemann JF
Pathol Res Pract; 2005; 200(11-12):801-5. PubMed ID: 15792123
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of Notch signaling enhances transdifferentiation of the esophageal squamous epithelium towards a Barrett's-like metaplasia via KLF4.
Vega ME; Giroux V; Natsuizaka M; Liu M; Klein-Szanto AJ; Stairs DB; Nakagawa H; Wang KK; Wang TC; Lynch JP; Rustgi AK
Cell Cycle; 2014; 13(24):3857-66. PubMed ID: 25558829
[TBL] [Abstract][Full Text] [Related]
55. Recent advances in Barrett's esophagus: short-segment Barrett's esophagus and cardia intestinal metaplasia.
Sharma P
Semin Gastrointest Dis; 1999 Jul; 10(3):93-102. PubMed ID: 10435696
[TBL] [Abstract][Full Text] [Related]
56. Barrett's esophagus and risk of esophageal adenocarcinoma.
Cossentino MJ; Wong RK
Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
[TBL] [Abstract][Full Text] [Related]
57. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
Triadafilopoulos G; Kaczynska M; Iwane M
Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
[TBL] [Abstract][Full Text] [Related]
58. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor.
Haigh CR; Attwood SE; Thompson DG; Jankowski JA; Kirton CM; Pritchard DM; Varro A; Dimaline R
Gastroenterology; 2003 Mar; 124(3):615-25. PubMed ID: 12612900
[TBL] [Abstract][Full Text] [Related]
59. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure.
Oberg S; DeMeester TR; Peters JH; Hagen JA; Nigro JJ; DeMeester SR; Theisen J; Campos GM; Crookes PF
J Thorac Cardiovasc Surg; 1999 Mar; 117(3):572-80. PubMed ID: 10047662
[TBL] [Abstract][Full Text] [Related]
60. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all.
Rajendra S; Kutty K; Karim N
Dig Dis Sci; 2004 Feb; 49(2):237-42. PubMed ID: 15104363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
